| Product Code: ETC10772519 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of peripheral intervention drug-eluting devices in Guatemala in 2024 continued to see a diverse range of countries exporting, with the top exporters being the USA, China, Mexico, Germany, and India. The low concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive market. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 8.8%, showing sustained market expansion. Additionally, the growth rate from 2023 to 2024 stood at a healthy 3.46%, indicating a positive trajectory for the industry in Guatemala.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Guatemala Country Macro Economic Indicators |
3.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.7 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in Guatemala |
4.2.2 Technological advancements in drug-eluting devices for peripheral interventions |
4.2.3 Growing awareness about minimally invasive procedures for peripheral artery treatments |
4.3 Market Restraints |
4.3.1 High cost associated with drug-eluting devices |
4.3.2 Limited reimbursement policies for peripheral interventions in Guatemala |
5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031F |
6.1.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2021 - 2031F |
6.1.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2021 - 2031F |
6.1.7 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031F |
6.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2021 - 2031F |
6.2.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2021 - 2031F |
6.2.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2021 - 2031F |
6.2.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2021 - 2031F |
6.2.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2021 - 2031F |
6.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.3.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031F |
6.3.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2021 - 2031F |
6.3.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2021 - 2031F |
6.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2021 - 2031F |
6.4.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2021 - 2031F |
6.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2021 - 2031F |
6.5.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2021 - 2031F |
6.5.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2021 - 2031F |
6.5.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031F |
6.5.6 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
7 Guatemala Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 Guatemala Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 Guatemala Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Number of peripheral artery disease cases diagnosed annually |
8.2 Adoption rate of drug-eluting devices in peripheral interventions |
8.3 Average procedure cost for using drug-eluting devices |
8.4 Rate of growth in the number of healthcare facilities offering peripheral interventions |
8.5 Patient satisfaction levels post peripheral intervention with drug-eluting devices |
9 Guatemala Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 Guatemala Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
9.3 Guatemala Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Guatemala Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Guatemala Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Guatemala Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 Guatemala Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
10.2 Guatemala Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here